Update README.md
Browse files
README.md
CHANGED
@@ -357,6 +357,7 @@ for split_schema in split_schemas:
|
|
357 |
|
358 |
### Customized Schema Description Instructions
|
359 |
|
|
|
360 |
```json
|
361 |
{
|
362 |
"instruction": "You are an expert specializing in entity extraction. Please extract entities that comply with the defined schema from the input; return an empty list for non-existent entity types. Please respond in JSON string format.",
|
@@ -442,6 +443,7 @@ for split_schema in split_schemas:
|
|
442 |
|
443 |
|
444 |
<details>
|
|
|
445 |
<summary><b>Knowledge Graph Construction (KGC) Description Instructions</b></summary>
|
446 |
|
447 |
```json
|
@@ -502,10 +504,10 @@ Given that example instances can often be lengthy, and due to the limited maximu
|
|
502 |
}
|
503 |
```
|
504 |
|
505 |
-
|
506 |
<details>
|
507 |
|
508 |
<summary><b>Relationship Extraction (RE) Example Instruction</b></summary>
|
|
|
509 |
```json
|
510 |
{
|
511 |
"instruction": "You are an expert specialized in relationship extraction. Please extract from the input the defined relation triples according to the schema; return an empty list for non-existent relations. Please respond in the format of a JSON string. You may refer to the example for guidance on extraction.",
|
@@ -550,7 +552,7 @@ Given that example instances can often be lengthy, and due to the limited maximu
|
|
550 |
"input": "(2)NSAIDs: This includes both non-selective cyclooxygenase (COX) inhibitors and COX-2 inhibitors. If there are no contraindications, early and ample use of fast-acting NSAID formulations is recommended. Non-selective COX inhibitors primarily have gastrointestinal adverse reactions such as ulcers, perforations, and upper gastrointestinal bleeding, hence COX-2 inhibitors, which can reduce GI reactions by 50%, may be used for those intolerant to non-selective COX inhibitors. Active gastrointestinal ulcers/bleeding or a history of recurrent gastrointestinal ulcers/bleeding is a contraindication for all NSAIDs use. COX-2 inhibitors may increase the risk of cardiovascular events and should be avoided in patients with myocardial infarction or heart failure. Kidney function monitoring is required during the use of NSAIDs, and their use is not recommended in patients with severe chronic kidney disease (stages G4 to G5) who are not undergoing dialysis."
|
551 |
}
|
552 |
```
|
553 |
-
|
554 |
</details>
|
555 |
|
556 |
|
@@ -558,6 +560,7 @@ Given that example instances can often be lengthy, and due to the limited maximu
|
|
558 |
<details>
|
559 |
|
560 |
<summary><b>Event Extraction (EE) Example Instruction</b></summary>
|
|
|
561 |
```json
|
562 |
{
|
563 |
"instruction": "You are an expert specialized in event extraction. Please extract events from the input according to the defined schema; return an empty list for non-existent events, and 'NAN' for non-existent arguments. If an argument has multiple values, please return a list. Respond in the format of a JSON string. You may refer to the example for extraction guidance.",
|
@@ -606,7 +609,7 @@ Given that example instances can often be lengthy, and due to the limited maximu
|
|
606 |
"input": "【Exclusive】The 11th in five years, Codemao announces completion of C+ round financing of 250 million yuan\nJiemodui, April 17th - Today, Codemao announced the completion of a C+ round of financing worth 250 million yuan.\nThis comes five months after completing a C round financing of 400 million yuan last year, which is the new round of 'ammunition' added by Codemao.\nThe round was led by China Merchants International, with Bohai Capital, an equity investment fund under Bank of China Group, and existing shareholders Yueke Xintai and Shengyu Investment following suit."
|
607 |
}
|
608 |
```
|
609 |
-
|
610 |
</details>
|
611 |
|
612 |
|
|
|
357 |
|
358 |
### Customized Schema Description Instructions
|
359 |
|
360 |
+
|
361 |
```json
|
362 |
{
|
363 |
"instruction": "You are an expert specializing in entity extraction. Please extract entities that comply with the defined schema from the input; return an empty list for non-existent entity types. Please respond in JSON string format.",
|
|
|
443 |
|
444 |
|
445 |
<details>
|
446 |
+
|
447 |
<summary><b>Knowledge Graph Construction (KGC) Description Instructions</b></summary>
|
448 |
|
449 |
```json
|
|
|
504 |
}
|
505 |
```
|
506 |
|
|
|
507 |
<details>
|
508 |
|
509 |
<summary><b>Relationship Extraction (RE) Example Instruction</b></summary>
|
510 |
+
|
511 |
```json
|
512 |
{
|
513 |
"instruction": "You are an expert specialized in relationship extraction. Please extract from the input the defined relation triples according to the schema; return an empty list for non-existent relations. Please respond in the format of a JSON string. You may refer to the example for guidance on extraction.",
|
|
|
552 |
"input": "(2)NSAIDs: This includes both non-selective cyclooxygenase (COX) inhibitors and COX-2 inhibitors. If there are no contraindications, early and ample use of fast-acting NSAID formulations is recommended. Non-selective COX inhibitors primarily have gastrointestinal adverse reactions such as ulcers, perforations, and upper gastrointestinal bleeding, hence COX-2 inhibitors, which can reduce GI reactions by 50%, may be used for those intolerant to non-selective COX inhibitors. Active gastrointestinal ulcers/bleeding or a history of recurrent gastrointestinal ulcers/bleeding is a contraindication for all NSAIDs use. COX-2 inhibitors may increase the risk of cardiovascular events and should be avoided in patients with myocardial infarction or heart failure. Kidney function monitoring is required during the use of NSAIDs, and their use is not recommended in patients with severe chronic kidney disease (stages G4 to G5) who are not undergoing dialysis."
|
553 |
}
|
554 |
```
|
555 |
+
|
556 |
</details>
|
557 |
|
558 |
|
|
|
560 |
<details>
|
561 |
|
562 |
<summary><b>Event Extraction (EE) Example Instruction</b></summary>
|
563 |
+
|
564 |
```json
|
565 |
{
|
566 |
"instruction": "You are an expert specialized in event extraction. Please extract events from the input according to the defined schema; return an empty list for non-existent events, and 'NAN' for non-existent arguments. If an argument has multiple values, please return a list. Respond in the format of a JSON string. You may refer to the example for extraction guidance.",
|
|
|
609 |
"input": "【Exclusive】The 11th in five years, Codemao announces completion of C+ round financing of 250 million yuan\nJiemodui, April 17th - Today, Codemao announced the completion of a C+ round of financing worth 250 million yuan.\nThis comes five months after completing a C round financing of 400 million yuan last year, which is the new round of 'ammunition' added by Codemao.\nThe round was led by China Merchants International, with Bohai Capital, an equity investment fund under Bank of China Group, and existing shareholders Yueke Xintai and Shengyu Investment following suit."
|
610 |
}
|
611 |
```
|
612 |
+
|
613 |
</details>
|
614 |
|
615 |
|